SCHEMBL24034720

SCHEMBL24034720

c1ccc2c(c1)c1cccc3c1n2c1ccccc1n1c2ccccc2c2ccc4c5ccccc5n3c4c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.44
FTO Q9C0B1 1/20 0.44
KDM4E B2RXH2 4/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
POLB P06746 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 1/20 0.43
GPR3 P46089 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HSP90AA1 P07900 1/20 0.35
IDO1 P14902 1/20 0.35
DUSP3 P51452 1/20 0.35
CYP19A1 P11511 1/20 0.34
BACE1 P56817 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24034725 0.93 ALKBH5 (0.48) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL15434837 0.93 ALKBH5 (0.48) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL15434846 0.93 GPR3 (0.46) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL19541231 0.88 KDM4E (0.52) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL24434250 0.86 KDM4E (0.50) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL29600269 0.85 KDM4E (0.53) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL867663 0.85 KDM4E (0.53) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL23729052 0.85 KDM4E (0.44) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL21453813 0.83 MAPT (0.52) ALKBH5FTOKDM4EMEN1MAPT
SCHEMBL20857813 0.83 KDM4E (0.52) ALKBH5FTOKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210355092-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355092-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OXA1L ALKBH5 488/4885FTO 40/4885KDM4E 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.